Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01
Published April 8, 2020 · Recall initiated: March 30, 2020
Summary
FDA records drug Class II recall D-1071-2020, published April 8, 2020 and initiated March 30, 2020. Recalling firm: Par Pharmaceutical Inc.; Status: Terminated; Reported quantity: 29,352 bottles; Lot: Lot # 32809101, Exp 3/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Par Pharmaceutical Inc.
- Distributor
- Product was distributed within the United States.
- Lot
- Lot # 32809101, Exp 3/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01September 2, 2020
- FDAGentamicin 80mg/60 mL Irrigation, containers, The Medicine Shoppe, 3524 B Tamiami Trail Port Charlotte, FLApril 8, 2020
- FDAMedtronic MiniMed Paradigm Insulin pump, model number MMT-723April 1, 2020
- FDAPrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NYMarch 25, 2020
- FDAFrovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only,February 19, 2020
- FDAMeclizine Hydrochloride Tablets USP, 25 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-035-01) and b)November 25, 2015
Questions about this recall
Was Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01 recalled?
Yes. FDA published recall D-1071-2020 on April 8, 2020. Reported hazard: Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter